SanjeevPathakMD

Psychiatry • Wilmington, DE

Child & Adolescent Psychiatry

Psychiatrist

Join to view full profile

Dr. Pathak is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Pathak's full profile

Already have an account?

Office
825 Washington St
Wilmington, DE 19801
Phone+1 302-655-7110

Fax+1 302-655-6185
Is this information wrong?

Education & Training

Cincinnati Children's Hospital Medical CenterFellowship, Child and Adolescent Psychiatry, 1999 - 2001
University of Cincinnati Medical Center/College of MedicineResidency, Psychiatry, 1996 - 1999
All India Institute of Medical SciencesClass of 1992

Certifications & Licensure

OH State Medical License 1999 - 2026
DE State Medical License 2010 - 2015

Clinical Trials

A Study of Different Titration Schedules of ALKS 5461 in Adults With Major Depressive Disorder (MDD) Start of enrollment: 2014 Feb 01
Completed
Phase 3
A Long-Term Safety Study of ALKS 5461 Start of enrollment: 2014 May 01
Completed
Phase 3
A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - the FORWARD-4 Study Start of enrollment: 2014 May 01
Completed
Phase 3
A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - the FORWARD-3 Study Start of enrollment: 2014 May 01
Completed
Phase 3
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder Start of enrollment: 2014 May 01
Completed
Phase 2
A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - FORWARD-5 Study Start of enrollment: 2014 Jul 01
Completed
Phase 3
A Study of the Abuse Liability Potential of Samidorphan in Healthy, Non-Dependent, Recreational Opioid Users Start of enrollment: 2014 Aug 01
Completed
Phase 1
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia Start of enrollment: 2017 Nov 15
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

Pimavanserin for psychosis in Parkinson's disease dementia: Subgroup analysis of the HARMONY Trial.
Abler, V., Stankovic, S., Weintraub, D., Espay, A., Sharma, V., Tariot, P., Pathak, S.> ;Parkinsonism & Related Disorders. 2024 Feb 1
44 citations
Opioid system modulation with buprenorphine/samidorphan combination for major depressive disorder: two randomized controlled studies.
Maurizio Fava, Michael E. Thase, Madhukar H. Trivedi, Elliot Ehrich, William F. Martin, Asli Memisoglu, Narinder Nangia, Arielle D. Stanford, Miao Yu, Sanjeev Pathak> ;Molecular Psychiatry. 2020 Jul 1
2 citations
Course of Psychosis in Schizophrenia With Alcohol Use Disorder: A Post Hoc Analysis of the Clinical Antipsychotic Trials of Intervention Effectiveness in Schizophrenia...
Sanjeev Pathak, Ying Jiang, Lauren DiPetrillo, Mark S. Todtenkopf, Yan Liu, Christoph U. Correll> ;The Journal of Clinical Psychiatry. 2020 Mar 17
11 citations
Results from a long-term open-label extension study of adjunctive buprenorphine/samidorphan combination in patients with major depressive disorder.
Michael E. Thase, Arielle D. Stanford, Asli Memisoglu, William F. Martin, Amy Claxton, J. Alexander Bodkin, Madhukar H. Trivedi, Maurizio Fava, Miao Yu, Sanjeev Pathak> ;Neuropsychopharmacology. 2019 Jun 29
17 citations
Buprenorphine/samidorphan combination for the adjunctive treatment of major depressive disorder: results of a phase III clinical trial (FORWARD-3).
John Zajecka, Arielle D. Stanford, Asli Memisoglu, William F. Martin, Sanjeev Pathak> ;Neuropsychiatric Disease and Treatment. 2019 Apr 4
50 citations
Mitigation of Olanzapine-Induced Weight Gain With Samidorphan, an Opioid Antagonist: A Randomized Double-Blind Phase 2 Study in Patients With Schizophrenia.
William F. Martin, Christoph U. Correll, Peter J. Weiden, Ying Jiang, Sanjeev Pathak, Lauren DiPetrillo, Bernard L. Silverman, Elliot Ehrich> ;The American Journal of Psychiatry. 2019 Mar 8
7 citations
Abuse Potential of Buprenorphine/Samidorphan Combination Compared to Buprenorphine and Placebo: A Phase 1 Randomized Controlled Trial
Sanjeev Pathak, Bradley Vince, Debra Kelsh, Megan J. Shram, Beatrice Setnik, Hong Lu, Narinder Nangia, Arielle D. Stanford, Elliot Ehrich> ;Journal of Clinical Pharmacology. 2019 Feb 1
10 citations
Abuse Potential of Samidorphan: A Phase I, Oxycodone-, Pentazocine-, Naltrexone-, and Placebo-Controlled Study
Sanjeev Pathak, Bradley Vince, Debra Kelsh, Beatrice Setnik, Narinder Nangia, Lauren DiPetrillo, Matthew D. Puhl, Lei Sun, Arielle D. Stanford, Elliot Ehrich> ;Journal of Clinical Pharmacology. 2019 Feb 1
83 citations
Adjunctive Lanicemine (AZD6765) in Patients with Major Depressive Disorder and History of Inadequate Response to Antidepressants: A Randomized, Placebo-Controlled Study.
Gerard Sanacora, Michael R Johnson, Arif Khan, Sarah Atkinson, Robert R Riesenberg, Juan P Schronen, Michael A Burke, John Zajecka, Luis Barra, Hong-Lin Su, Joel A. Po...> ;Neuropsychopharmacology. 2017 Mar 1
6 citations
Cataractogenic potential of quetiapine versus risperidone in the long-term treatment of patients with schizophrenia or schizoaffective disorder: a randomized, open-lab...
Alan M. Laties, Allan J. Flach, Irina Baldycheva, Ihor Rak, Willie Earley, Sanjeev Pathak> ;Journal of Psychopharmacology. 2015 Jan 1
172 citations
Lanicemine: a low-trapping NMDA channel blocker produces sustained antidepressant efficacy with minimal psychotomimetic adverse effects
Gerard Sanacora, Mark A. Smith, Sanjeev Pathak, Su Hl, Boeijinga Ph, Dennis J. McCarthy, Michael Quirk> ;Molecular Psychiatry. 2014 Sep 1
48 citations
Efficacy and safety of extended-release quetiapine fumarate in youth with bipolar depression: an 8 week, double-blind, placebo-controlled trial.
Robert L. Findling, Sanjeev Pathak, Willie Earley, Sherry Liu, Melissa P. DelBello> ;Journal of Child and Adolescent Psychopharmacology. 2014 Aug 19
4 citations
Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in patients with generalized anxiety disorder and a history of inadequate treatment response...
Arifulla Khan, Sarah Atkinson, Irina Mezhebovsky, Fahua She, Todd Leathers, Sanjeev Pathak> ;Annals of Clinical Psychiatry. 2014 Feb 1
4 citations
Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in patients with generalized anxiety disorder and a history of inadequate treatment response...
Arifulla Khan, Sarah Atkinson, Irina Mezhebovsky, Fahua She, Todd Leathers, Sanjeev Pathak> ;Annals of Clinical Psychiatry. 2014 Feb 1
17 citations
Safety, tolerability, and efficacy of quetiapine in youth with schizophrenia or bipolar I disorder: a 26-week, open-label, continuation study.
Robert L. Findling, Sanjeev Pathak, Willie Earley, Sherry Liu, Melissa P. DelBello> ;Journal of Child and Adolescent Psychopharmacology. 2013 Sep 16
39 citations
Efficacy and safety of quetiapine in children and adolescents with mania associated with bipolar I disorder: a 3-week, double-blind, placebo-controlled trial.
Sanjeev Pathak, Robert L. Findling, Willie Earley, Larisa D. Acevedo, Jill Stankowski, Melissa P. DelBello> ;The Journal of Clinical Psychiatry. 2013 Jan 15
42 citations
Efficacy and Safety of Quetiapine in Adolescents with Schizophrenia Investigated in a 6-Week, Double-Blind, Placebo-Controlled Trial
Robert L. Findling, Kathleen M. McKenna, Willie Earley, Jill Stankowski, Sanjeev Pathak> ;Journal of Child and Adolescent Psychopharmacology. 2012 Oct 19
1 citations
The Promise of Rapidly Acting Antidepressants: Challenges and Opportunities
Mark A. Smith, Sanjeev Pathak> ;Biological Psychiatry. 2012 Aug 15
35 citations
Glutamate-based depression GBD.
Dennis J. McCarthy, Robert C. Alexander, Mark A. Smith, Sanjeev Pathak, Stephen J. Kanes, Chi-Ming Lee, Gerard Sanacora> ;Medical Hypotheses. 2012 May 1
15 citations
Development and content validity of a patient reported outcomes measure to assess symptoms of major depressive disorder.
Kathryn Eilene Lasch, Mariam Hassan, Jean Endicott, Elisabeth Carine Piault-Luis, Julie C. Locklear, Marcy Fitz-Randolph, Sanjeev Pathak, Steve Hwang, Kasey Jernigan> ;BMC Psychiatry. 2012 Apr 25
1 citations
Extended Release Quetiapine Fumarate (Quetiapine XR) as Adjunct Therapy in Patients with Generalized Anxiety Disorder and a History of Inadequate Treatment Response: A...
Arifulla Khan, Sarah Atkinson, Irina Mezhebovsky, Fahua She, Todd Leathers, Sanjeev Pathak> ;Psychopharmacology Bulletin. 2011 May 15
49 citations
An Exploratory Analysis of the Impact of Family Functioning on Treatment for Depression in Adolescents.
Norah C. Feeny, Susan G. Silva, Mark A. Reinecke, Steven McNulty, Robert L. Findling, Paul Rohde, John F. Curry, Golda S. Ginsburg, Christopher J. Kratochvil, Sanjeev ...> ;Journal of Clinical Child and Adolescent Psychology. 2009 Nov 11
26 citations
The Dysfunctional Attitudes Scale: Psychometric Properties in Depressed Adolescents.
Gregory M. Rogers, Jong Hyo Park, Marilyn J. Essex, Marjorie H. Klein, Susan G. Silva, Rick H. Hoyle, John F. Curry, Norah C. Feeny, Betsy D. Kennard, Christopher J. K...> ;Journal of Clinical Child and Adolescent Psychology. 2009 Nov 11
91 citations
The treatment for adolescents with depression study (TADS): Outcomes over 1 year of naturalistic follow-up
John S. March, Susan G. Silva, John F. Curry, Karen C. Wells, John A. Fairbank, Barbara J. Burns, Marisa Elena Domino, Benedetto Vitiello, Joanne B. Severe, Charles D....> ;The American Journal of Psychiatry. 2009 Oct 1
11 citations
Drug-metabolizing enzyme genotypes and aggressive behavior treatment response in hospitalized pediatric psychiatric patients.
Cynthia A. Prows, Todd G. Nick, Shannon N. Saldaña, Sanjeev Pathak, Chunyan Liu, Kejian Zhang, Zachary S. Daniels, Alexander A. Vinks, Tracy A. Glauser> ;Journal of Child and Adolescent Psychopharmacology. 2009 Aug 24
Join now to see all

Authored Content

S99. Evaluation of Abuse Potential of Samidorphan in Healthy, Nondependent, Recreational Opioid UsersApril 2018
S99. Evaluation of Abuse Potential of Samidorphan in Healthy, Nondependent, Recreational Opioid UsersApril 2018

SanjeevPathakMD

Dr. Pathak is on Doximity

Education & Training

Certifications & Licensure

Clinical Trials

Publications & Presentations

Authored Content

Viewing the full profile is available to verified healthcare professionals only.